Replies to post #524664 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

The NYAS paper said it. Plus it is obvious from the source of the data being published papers and patient level data is not in the papers.

Matching Adjusted Indirect Comparison (MAIC) methodology used to adjust for even small differences in individual patient characteristics. Comparison of DCVax-L vs. external controls OS remained statistically significant. (Propensity score matching was not feasible with the available data.)

As LL wrote that statement, why are you accusing her of lying?